nach oben

Reactions Weekly

Erschienen in:

01.06.2019 | Case report

Palbociclib

Neutropenia: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Angelis V, et al. Haematological Toxicity Surveillance in the Management of Patients with ER-positive Metastatic Breast Cancer Receiving Palbociclib: is Nurse-led Review on Day 14 Necessary?. Clinical Oncology 31: e105, No. 7, Jul 2019. Available from: URL: http://doi.org/10.1016/j.clon.2019.03.007 [abstract] - United Kingdom

Titel: Palbociclib
Neutropenia: 2 case reports
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-64095-8

Propofol

Case report

Infliximab

Case report

Adenovirus-vaccine/listeria-monocytogenes-vaccine

Case report

Paclitaxel

Case report

Immune-globulin/mycophenolate/prednisone

Case report

RXQ Compounding voluntarily recalls all sterile products

News item

Springer Medizin

Palbociclib

Neutropenia: 2 case reports

Excerpt

Weitere Artikel der Ausgabe 1/2019

Propofol

Infliximab

Adenovirus-vaccine/listeria-monocytogenes-vaccine

Paclitaxel

Immune-globulin/mycophenolate/prednisone

RXQ Compounding voluntarily recalls all sterile products

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Propofol

Infliximab

Adenovirus-vaccine/listeria-monocytogenes-vaccine

Paclitaxel

Immune-globulin/mycophenolate/prednisone

RXQ Compounding voluntarily recalls all sterile products